Positron Emission Tomography/Computed Tomography in Esophageal Carcinoma: Applications and Limitations

被引:1
作者
Cuellar, Sonia L. Betancourt [1 ]
Palacio, Diana P. [2 ]
Benveniste, Marcelo F. [1 ]
Carter, Brett W. [1 ]
Hofstetter, Wayne L. [1 ]
Marom, Edith M. [1 ,3 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, 1515 Holcombe Blvd, Houston, TX 77030 USA
[2] Univ Anzona, Med Ctr, Dept Diagnost Radiol, Tucson, AZ USA
[3] Chaim Sheba Med Ctr, Dept Diagnost Imaging, Ramat Gan, Israel
[4] Tel Aviv Univ, Tel Aviv, Israel
关键词
SQUAMOUS-CELL CARCINOMA; METABOLIC TUMOR VOLUMES; LYMPH-NODE; ESOPHAGOGASTRIC JUNCTION; NEOADJUVANT THERAPY; FDG-PET; ENDOSCOPIC ULTRASOUND; DISTANT METASTASES; PROGNOSTIC-FACTOR; HISTOLOGIC TYPE;
D O I
10.1053/j.sult.2017.07.008
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Squamous cell carcinoma and adenocarcinoma represent approximately 98% of esophageal malignant tumors. During the last 30 years, the incidence of adenocarcinoma has increased in Western countries (including the USA) where adenocarcinoma currently represents more than 60% of esophageal malignancies, although, worldwide, squamous cell carcinoma continues to be the predominant histologic type. Integrated positron emission tomography or computed tomography with 2-Efluorine181 fluro-2-deoxy-o-glucose is used in many institutions routinely as a tool in the initial staging and then repeated after therapy for the assessment of response to neoadjuvant therapy and detection of recurrent disease in patients with esophageal carcinoma. As with any other imaging modality, 2-[fluorine18] fluro-2-deoxy-D-glucose-positron emission tomography or computed tomography has strengths and limitations that should be understood in order to maximize its utility. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:571 / 583
页数:13
相关论文
共 50 条
[21]   Positron emission tomography/computed tomography for lung cancer staging [J].
de Guevara H, David Ladron ;
Furnaro L, Francisca ;
Yevenes A, Sebastian ;
Clavero R, Jose Miguel ;
Lazo P, David ;
Rodriguez D, Patricio ;
Piottante B, Antonio ;
Pefaur D, Raul ;
Pardo B, Claudio .
REVISTA MEDICA DE CHILE, 2015, 143 (01) :22-29
[22]   Appropriate indications for positron emission tomography/computed tomography, 2015 [J].
Vorster, M. ;
Doruyter, A. ;
Brink, A. ;
Mkhize, S. ;
Holness, J. ;
Malan, N. ;
Nyakale, N. ;
Warwick, J. M. ;
Sathekge, M. .
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2016, 106 (01) :106-122
[23]   Positron Emission Tomography in Merkel Cell Carcinoma [J].
Sachpekidis, Christos ;
Sidiropoulou, Polytimi ;
Hassel, Jessica C. ;
Drakoulis, Nikolaos ;
Dimitrakopoulou-Strauss, Antonia .
CANCERS, 2020, 12 (10) :1-18
[24]   Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study [J].
Nowee, M. E. ;
Voncken, F. E. M. ;
Kotte, A. N. T. J. ;
Goense, L. ;
van Rossum, P. S. N. ;
van Lier, A. L. H. M. W. ;
Heijmink, S. W. ;
Aleman, B. M. P. ;
Nijkamp, J. ;
Meijer, G. J. ;
Lips, I. M. ;
Braam, P. M. ;
Buijsen, J. ;
Ceha, H. M. ;
Dewit, L. ;
Franssen, J. H. ;
van Gestel, K. ;
Grootenboers, D. A. R. H. ;
Intven, M. ;
Jansen, E. P. M. ;
Kerkmeijer, L. G. W. ;
Mul, V. E. ;
Muller, K. ;
Neelis, K. J. ;
Oppedijk, V ;
Rozema, T. ;
Spruit, P. H. .
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 14 :33-39
[25]   18F-fluorodeoxyglucose positron emission computed tomography for monitoring tumor response in esophageal carcinoma treated with concurrent chemoradiotherapy [J].
Zhang, Peiliang ;
Li, Zengyun ;
Wang, Dongqing ;
Ma, Fuling ;
Zhang, Ran ;
Liang, Wanhua ;
Sun, Mingping ;
Fu, Zheng ;
Sun, Xiaorong .
ONCOLOGY LETTERS, 2018, 15 (02) :1845-1852
[26]   The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer [J].
Duncan, James Robert ;
Carr, David ;
Kaffenberger, Benjamin Harris .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (01) :186-196
[27]   Updates in the Role of Positron Emission Tomography/Computed Tomography in Radiation Oncology in Gastrointestinal Malignancies [J].
Kumar, Ritesh ;
Shalaby, Ahmed ;
Narra, Lakshmi Rekha ;
Gokhale, Shivani ;
Deek, Matthew P. ;
Jabbour, Salma K. .
PET CLINICS, 2025, 20 (02) :219-229
[28]   Positron emission tomography/computed tomography imaging features of renal cell carcinoma and pulmonary metastases in a dog [J].
Song, Sun-Hye ;
Park, Noh-Won ;
Eom, Ki-Dong .
CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 2014, 55 (05) :466-470
[29]   Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers [J].
Gauthe, Mathieu ;
Richard-Molard, Marion ;
Cacheux, Wulfran ;
Michel, Pierre ;
Jouve, Jean-Louis ;
Mitry, Emmanuel ;
Alberini, Jean-Louis ;
Lievre, Astrid .
DIGESTIVE AND LIVER DISEASE, 2015, 47 (06) :443-454
[30]   Detection of Metastatic Cervical Lymph Nodes in Recurrent Papillary Thyroid Carcinoma: Computed Tomography Versus Positron Emission Tomography-Computed Tomography [J].
Lee, Dong Hoon ;
Kang, Won Jun ;
Seo, Hyung Suk ;
Kim, Eunhee ;
Kim, Ji Hoon ;
Son, Kyu-Ri ;
Na, Dong Gyu .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2009, 33 (05) :805-810